Liquidia Corp.

Industry

  • Biotechnology
    • Synthesis Technologies, Production Processes
    • Drug Discovery Technologies
    • Nanotechnology, Chips, etc.
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
      • Controlled Release
    • Vaccines

Other Names/Subsidiaries

  • Liquidia Technologies, Inc.
See more in Biomedtracker

Latest on Liquidia Corp.

Scrip

Finance Watch: Cargo Restructuring Not The News The IPO Market Needs

 
• By Mandy Jackson

Cargo Therapeutics’ decision to end all development for its allogeneic cell therapy technology platform and its cancer cell therapy candidates is not the kind of news the biopharmaceutical sector need

Generics Bulletin

Sandoz And Liquidia Triumph On Treprostinil

 
• By Dave Wallace

Sandoz and its generic Remodulin (treprostinil) partner Liquidia have welcomed a US court opinion that concluded the firms suffered losses of more than $137m as a result of interference by originat

Pink Sheet

Life After Chevron: US Supreme Court Ruling Cited In FDA Exclusivity Decision Challenges

 
• By Sue Sutter

Legal challenges of US Food and Drug Administration exclusivity determinations are among the early cases where the Supreme Court’s overturning of the Chevron doctrine of deference is being cited. Th

Scrip

Deal Watch: Takeda Calls Upon The UK’s F-star Again For Bispecific Candidates

 
• By Joseph Haas and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Takeda, F-star Sign Joint Research Pact